ATE156016T1 - Glattmuskelrelaxierende arzneizubereitungen - Google Patents

Glattmuskelrelaxierende arzneizubereitungen

Info

Publication number
ATE156016T1
ATE156016T1 AT95115576T AT95115576T ATE156016T1 AT E156016 T1 ATE156016 T1 AT E156016T1 AT 95115576 T AT95115576 T AT 95115576T AT 95115576 T AT95115576 T AT 95115576T AT E156016 T1 ATE156016 T1 AT E156016T1
Authority
AT
Austria
Prior art keywords
smooth muscle
medicinal preparations
muscle relaxing
tryptophan
serine
Prior art date
Application number
AT95115576T
Other languages
English (en)
Inventor
Stefano Poli
Tiziano Crimella
Ambrogio Magni
Luigi Moro
Original Assignee
Poli Ind Chimica Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11369756&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE156016(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Poli Ind Chimica Spa filed Critical Poli Ind Chimica Spa
Application granted granted Critical
Publication of ATE156016T1 publication Critical patent/ATE156016T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT95115576T 1994-10-21 1995-10-02 Glattmuskelrelaxierende arzneizubereitungen ATE156016T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI942166A IT1271031B (it) 1994-10-21 1994-10-21 Composizioni farmaceutiche miorilassanti

Publications (1)

Publication Number Publication Date
ATE156016T1 true ATE156016T1 (de) 1997-08-15

Family

ID=11369756

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95115576T ATE156016T1 (de) 1994-10-21 1995-10-02 Glattmuskelrelaxierende arzneizubereitungen

Country Status (9)

Country Link
EP (1) EP0707853B1 (de)
AT (1) ATE156016T1 (de)
CA (1) CA2160938C (de)
DE (2) DE707853T1 (de)
DK (1) DK0707853T3 (de)
ES (1) ES2088379T3 (de)
GR (2) GR960300039T1 (de)
HK (1) HK1001719A1 (de)
IT (1) IT1271031B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6911455B2 (en) 1999-12-22 2005-06-28 Smithkline Beecham Corporation Methods for preparing pharmaceutical formulations
ATE359092T1 (de) * 1999-12-22 2007-05-15 Glaxo Group Ltd Verfahren zur herstellung pharmazeutischer formulierungen
DE102005030423A1 (de) * 2005-06-30 2007-01-04 Inresa Arzneimittel Gmbh Neue Formulierung für Vecuroniumbromid
CA2631243A1 (en) * 2005-12-08 2007-06-14 Wyeth Liposomal compositions
EP2712611A1 (de) 2012-09-27 2014-04-02 B. Braun Melsungen AG Stabilisierte wässrige Zusammensetzungen von neuromuskulären Blockiermitteln
RU2594062C2 (ru) * 2013-07-23 2016-08-10 Закрытое акционерное общество "ЭкоФармПлюс" Способ получения фармацевтического состава рокурония бромида в форме стабильного лиофилизата и фармацевтический состав, полученный этим способом
CN107638391B (zh) * 2016-07-22 2020-10-16 海南合瑞制药股份有限公司 一种注射用苯磺顺阿曲库铵组合物
CN108676052B (zh) * 2018-08-16 2020-05-22 北京市新里程医药科技有限公司 一种罗库溴铵的制备方法及其药物组合物
CN111374942B (zh) * 2018-12-30 2022-09-13 鲁南制药集团股份有限公司 一种甾体类肌松药注射液及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2130357A1 (en) * 1992-02-18 1993-08-19 Doron Friedman Dry compositions for preparing submicron emulsions
GB9302455D0 (en) * 1993-02-08 1993-03-24 Lab Inpharm N V Process for preparing a pharmaceutical preparation having neuromuscular blocking activity

Also Published As

Publication number Publication date
IT1271031B (it) 1997-05-26
ES2088379T1 (es) 1996-08-16
GR3024761T3 (en) 1997-12-31
ITMI942166A0 (it) 1994-10-21
DK0707853T3 (da) 1998-03-02
CA2160938C (en) 2008-07-15
GR960300039T1 (en) 1996-08-31
CA2160938A1 (en) 1996-04-22
ES2088379T3 (es) 1997-10-16
EP0707853A1 (de) 1996-04-24
HK1001719A1 (en) 1998-07-03
DE69500490D1 (de) 1997-09-04
EP0707853B1 (de) 1997-07-30
DE707853T1 (de) 1996-12-12
ITMI942166A1 (it) 1996-04-21
DE69500490T2 (de) 1997-12-04

Similar Documents

Publication Publication Date Title
PT792287E (pt) Analogos peptidicos da proteina basica da mielina humana
ATE306931T1 (de) Unterdrückung von veränderungen in zusammenhang mit beta-amyloid bei alzheimer
DE69614681D1 (de) Pharmazeutische und/oder diätische zusammensetzungen mit antioxydationswirkung, welche carnosin und verzweigte aminosäure enthalten
TR199901132T2 (xx) N-(aril/heteoaril) amino asit t�revleri, bunlar� i�eren farmas�tik bile�imler ve b�yle bile�ikler kullan�larak �-amiloid peptidinin sal�nmas�n� ve/veya sentezini inhibe etmek i�in y�ntemler.
NO965012D0 (no) Farmasöytisk preparat som omfatter glukagon
AU5989499A (en) Method for prevention and/or cosmetic treatment of skin striae and use in dermatology
BR9807076B1 (pt) "uso de acetato de glatirâmero para a fabricação de medicamento para o tratamento de esclerose múltipla e composição farmacêutica"
DE69635051T2 (de) Methode zur lösung, reinigung und rückfaltung von protein
FI963679L (fi) Stabiloitu koostumus peptidien antamiseksi suun kautta
DK0921812T3 (da) Insulinpræparater, som indeholder NaCi
RU94046091A (ru) Полипептидные антагонисты бомбезина, фармацевтическая композиция и способ лечения
ATE156016T1 (de) Glattmuskelrelaxierende arzneizubereitungen
BR0211186A (pt) peptìdeos e uso dos mesmos no escurecimento da pele
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
IL104574A (en) N-[[3,4-dichlorophenyl)amino] carbonyl]-2,3-dihydro benzofuran-5-sulfonamide its preparation and antitumor compositions containing it and uses thereof
DE69330268D1 (de) Hämoregulierende peptide
NO883468D0 (no) Fremgangsmaate til fremstilling av farmasoeytiske blandinger inneholdende cyklopeptider som reserpsjonsbefordrere ved applikasjon paa slimhuden.
YU20050685A (sh) Poboljšanje podnošljivosti farmaceutski delotvornih beta- amino kiselina
GEP20032975B (en) Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition
SE9901773D0 (sv) Förebyggande av karies i tänderna
SE0002232D0 (sv) Antioxidant
EA200100477A1 (ru) Фармацевтическая композиция тнр и эналаприла
EE04872B1 (et) a-tsklodekstriini v?i selle derivaadi kasutamineLH-RH peptiidanaloogi sisaldavate farmatseutiliste kompositsioonide valmistamiseks ja a-tsklodekstriinil p?hinev farmatseutiline kompositsioon LH-RHpeptiidanaloogide peroraalseks manustamiseks
BR0313432A (pt) Uso terapêutico de aminoácidos bicìclicos ou tricìclicos fundidos

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner